2022
Z.-q. Wang et al.
LETTER
2003, 59, 1749. (i) Evdokimov, N. M.; Magedov, I. V.;
Kireev, A. S.; Kornienko, A. Org. Lett. 2006, 8, 899.
(j) Evdokimov, N. M.; Kireev, A. S.; Yakovenko, A. A.;
Antipin, M. Y.; Magedov, I. V.; Kornienko, A. J. Org.
Chem. 2007, 72, 3443. (k) Ranu, B. C.; Jana, R.; Sowmiah,
S. J. Org. Chem. 2007, 72, 3152.
Acknowledgment
This work is supported by the Natural Science Foundation of China
(NSFC 20672009) and National Key Technology R&D Program
(No: 2007BAI34B00)
(4) (a) Zhao, Y.; Ge, Z. M.; Cheng, T. M.; Li, R. T. Synlett 2007,
10, 1529. (b) Lei, M.; Shi, L. X.; Li, G.; Chen, S.; Fang, W.
H.; Ge, Z. M.; Cheng, T. M.; Li, R. T. Tetrahedron 2007, 63,
7892.
References and Notes
(1) (a) Weber, L. Curr. Med. Chem. 2002, 9, 2085. (b) Hulme,
C.; Gore, V. Curr. Med. Chem. 2003, 10, 51. (c) Ramon,
D. J.; Miguel, Y. Angew. Chem. Int. Ed. 2005, 44, 1602.
(d) Orru, R. V. A.; de Greef, M. Synthesis 2003, 1471.
(e) Ugi, I.; Heck, S. Comb. Chem. High Throughput
Screening 2001, 4, 1. (f) Weber, L.; Illgen, K.; Almstetter,
M. Synlett 1999, 366.
(2) (a) Cocco, M. T.; Congiu, C.; Lilliu, V.; Onnis, V. Eur. J.
Med. Chem. 2005, 40, 1365; and references cited therein.
(b) Perrier, V.; Wallace, A. C.; Kaneko, K.; Safar, J.;
Prusiner, S. B.; Cohen, F. E. Proc. Natl. Acad. Sci. U.S.A.
2000, 97, 6073. (c) Reddy, T. R. K.; Mutter, R.; Heal, W.;
Guo, K.; Gillet, V. J.; Pratt, S.; Chen, B. J. Med. Chem. 2006,
49, 607. (d) Guo, K.; Mutter, R.; Heal, W.; Reddy, T. R. K.;
Cope, H.; Pratt, S.; Thompson, M. J.; Chen, B. Eur. J. Med.
Chem. 2008, 43, 93. (e) Beukers, M. W.; Chang, L. C. W.;
von Frijtag Drabbe Künzel, J. K.; Mulder-Krieger, T.;
Spanjersberg, R. F.; Brussee, J.; Ijzerman, A. P. J. Med.
Chem. 2004, 47, 3707. (f) Chang, L. C. W.;
(5) (a) Starks C. M., Liotta C. L., Halpern M.; Phase-Transfer
Catalysis:Fundamentals, Applications, and Industrial
Perspectives ; Chapman & Hall: New York, 1994.
(b) Halpern, M. E. Benefts and Challenges of Applying
Phase-Transfer Catalysis Technology in the Pharmaceutical
Industry, In Process Chemistry in the Pharmaceutical
Industry; Gadamasetti, K. G., Ed.; Marcel Dekker: New
York, 1999, 283. (c) Masaya, I. Org. Process Res. Dev.
2008, 12, 698. (d) Takuya, H.; Keiji, M. Chem. Rev. 2007,
107, 565.
(6) Representative Procedure for the Synthesis of
Compound 3a
A mixture of benzaldehyde (106 mg, 1 mmol), malononitrile
(132 mg, 2 mmol), NaOH (120 mg, 3 mmol), and SDS (29
mg, 0.1 mmol) in H2O (10 mL) was stirred for 10 min at r.t.
The S-methylisothiouronium sulfate (139 mg, 1 mmol) was
added. The reaction mixture was further stirred for 50 min
until the completion of the reaction (monitored by TLC).
The reaction mixture was then filtered and washed with H2O
to give the crude solid, which was recrystallized from MeCN
to furnish the crystals of 2-amino-4-phenyl-6-methyl-
sulfanylpyridine-3,5-dicarbonitrile (238 mg, 89%); mp 295–
296 °C. 1H NMR (300 MHz, CDCl3): d = 2.59 (s, 3 H,
von Frijtag Drabbe Künzel, J. K.; Mulder-Krieger, T.;
Spanjersberg, R. F.; Roerink, S. F.; van den Hout, G.;
Beukers, M. W.; Brussee, J.; Ijzerman, A. P. J. Med. Chem.
2005, 48, 2045.
(3) (a) Kambe, S.; Saito, K. Synthesis 1981, 531.
(b) Matrosova, S. V.; Zav’yalova, V. K.; Litvinov, V. P.;
Sharanin, Y. A. Izv. Akad. Nauk SSSR, Ser. Khim. 1991,
1643. (c) Elnagdi, M. H.; Elghandour, A. H. H.; Ibrahim,
M. K. A.; Hafiz, I. S. A. Z. Naturforsch., B: Chem. Sci. 1992,
47, 572. (d) Dyachenko, V. D.; Krivokolysko, S. G.;
Nesterov, V. N.; Litvinov, V. P. Chem. Heterocycl. Compd.
1997, 33, 1430. (e) Dyachenko, V. D.; Litvinov, V. P.
Chem. Heterocycl. Compd. 1998, 34, 188. (f) Dyachenko,
V. D.; Litvinov, V. P. Russ. J. Org. Chem. 1998, 34, 557.
(g) Quintela, J. M.; Peinador, C.; Veiga, M. C.; Botana,
L. M.; Alfonso, A.; Riguera, R. Eur. J. Med. Chem. 1998,
887. (h) Attia, A. M. E.; Ismail, A. E.-H. A. A. Tetrahedron
SCH3), 5.67 (br s, 2 H, NH2), 7.50–7.55 (m, 5 H, Ph). 13
C
NMR (75 MHz, DMSO-d6): d = 12.79, 85.55, 93.49, 115.31,
115.46, 128.42, 128.71, 130.33, 133.98, 158.17, 159.72,
167.53. Anal. Calcd for C14H10N4S2: C, 63.14; H, 3.78; N,
21.04. Found: C, 63.13; H, 3.96; N, 21.24.
This procedure was followed for all the reactions listed in
Table 1. The unknown compounds were properly
characterized by their spectroscopic (1H NMR, 13C NMR)
and elemental analysis. The known compounds were
confirmed by 1H NMR and mp which were consistent with
the reported data (see Supporting Information).
Synlett 2009, No. 12, 2020–2022 © Thieme Stuttgart · New York